Researchers reviewed medical records for 748 headache patients at 21 hospitals who underwent an inappropriate brain CT. Of those patients, 83 percent should not have been labeled as inappropriate based on either ACEP clinical policy guidelines or expert consensus standards. Specifically, when the patients’ medical records were reviewed, researchers found 65 percent of the CT scans actually complied with Medicare’s measure and another 18 percent of patients had valid reasons for the CTs documented on their charts.
Since the OP-15 measure was only 17 percent accurate in assessing which patients should receive a CT scan, researchers suggested the measure could have unintended consequences by “publicizing inaccurate information about clinical performance and rewarding hospitals based on unreliable data.”
Related Articles on Quality Measures:
Commentary: Standards Must Be Standardized, Harmonized
Admission Health Status Should Be Accounted For in New Payment, Incentive Models
Study: Small Hospitals Less Likely to Provide Full Heart Failure Care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
